ICTUS: Invasive versus conservative treatment in unstable coronary syndromes

      -3-Year Follow-Up by Dr. R.J. De Winter (ESC 2006)

      -6-Month Results by Dr. R.J. De Winter (ESC 2004)

IDEAL: Incremental Decrease In End Points through Aggressive Lipid Lowering

      -Trial Overview by Dr. Terje Pedersen (AHA 2005)

      -Background, Study Rationale and Endpoints by the IDEAL Steering Committee and Investigators (2005)

ILLUMINATE: Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events

      -Final Results by Dr. Philip J. Barter (AHA 2007)

ILLUSTRATE: Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation

      -Trial Overview by Dr. Steven E. Nissen (ACC 2007)

      -Results by Dr. Steven E. Nissen

      -ILLUSTRATE en espanol by Dr. Steven E. Nissen (ACC 2007) Spanish

IMAGINE: Ichemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme

      - Trial Overview by Dr. W H van Gilst (ESC 2005)

Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men:

      -Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men by Dr. Harry Hemingway

INCITE: INflammatory Cessation with abcIximab or InTEgrilin

      -Trial Overview by Dr. Frederick Welt and Dr. Daniel I. Simon

Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI

      -Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI by Dr. Duane S. Pinto

INTAMI: Integrilin in Acute Myocardial Infarction

      -Early Eptifibatide Improves TIMI 3 Patency Before Primary PCI for Acute STEMI: Results of the INTAMI Pilot Trial by Dr. Uwe Zeymer (April 27, 2005)

INTEGRITI: Integrilin and Tenecteplase in Acute Myocardial Infarction

      -Combination Reperfusion Therapy with Eptifibatide and Reduced-Dose Tenecteplase in Acute Myocardial Infarction:Results from the Phase II Angiographic Trial by Dr. Robert Giugliano

INTERACT: The INTegrelin and Enoxaparin Randomized assessment of Acute Coronary syndrome Treatment Trial

      -Trial Overview by Dr. Shaun G. Goodman (ACC 2002)

Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

      -Trial Results by Dr. Stefan Janssens (ACC 2005)

INTRINSIC RV: Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs Trial

      -Trial Overview by Dr. Brian Olshansky (Heart Rhythm Society Meeting, May 2006)

INTRO AMI: INTegrilin and Reduced Dose of Thrombolytic in Acute Myocardial Infarction

      -Trial Overview

INVEST: International Verapamil SR - Trandolapril Study

      -Main Outcomes, Predictors of Risk, Diabetes, New Diabetes, BP and Depression/QOL Sub-analyses by Dr. Carl J. Pepine

I-PRESERVE: Irbesartan in Heart Failure with Preserved EF

      -Trial Overview by Dr. Peter Carson and Dr. Barry Massie

ISAR-DESIRE: Drug-Eluting Stents for In-Stent Restenosis

      -Trial Overview by Dr. Adnan Kastrati (ESC 2004)

ISAR-DESIRE 2: Drug-Eluting Stents For In-Stent Restenosis

      -Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents by Dr. Robert A. Byrne, et al. (TCT 2009)

ISAR-DIABETES: Sirolimus-eluting Stent compared with Paclitaxel-eluting stent for Coronary Revascularization

      -Trial Overview by Dr. Adnan Kastrati (ACC 2005)

ISAR Left Main Study: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

      -Trial Overview by Dr. J. Mehilli

ISAR-REACT: Rapid Early Action for Coronary Treatment

      -ACC 2003 Late-Breaking Clinical Trial Presentation

ISAR-REACT 2: Rapid Early Action for Coronary Treatment

      -Trial Overview by Dr. Adnan Kastrati (ACC 2006)

      -One-year Clinical Outcomes in the ISAR-REACT 2 Trial, a Randomized Comparison of Abciximab Versus Placebo in Patients With non-ST Segment Elevation Acute Coronary Syndromes Undergoing PCI After Pretreatment With Clopidogrel by Dr. M. Seyfarth (ESC 2007)

ISAR-REACT 3: Rapid Early Action for Coronary Treatment

      -Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients with Stable and Unstable Angina Undergoing PCI by Dr. Adnan Kastrati (ACC 2008)

ISAR-SWEET

      - Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics by Dr. Julinda Mehilli (AHA 2004)

ISAR-TEST 2

      -Results from a Test of the Efficacy of 3 Limus-Eluting Stents by Dr. Robert A. Byrne (TCT 2007)

ISAR-TEST 3

      -Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis by Dr. Julinda Mehilli

ISAR-TEST 4: Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies

      -Randomized, Non-inferiority Trial of 3 Limus Agent-Eluting Stents With Different Polymer Coatings by Dr. J. Mehilli

ISAR-TEST 4: Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

     -Two-Year Clinical and Angiographic Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents and
Sirolimus-Eluting Stents in Patients with Coronary Artery Disease by Dr. Robert A. Byrne (TCT 2010)

IV ANP in STEMI

      -Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with First Anterior Acute Myocardial Infarction by Dr. Shu Kasama

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs